SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 77 filers reported holding SAVARA INC in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,731 | – | 1,200 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 42 | -70.4% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 142 | -22.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 184 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 184 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 184 | -10.7% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 206 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 206 | -2.8% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 212 | -41.8% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 364 | +156.3% | 0.00% | – |
| Q1 2016 | $1,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |